Healthcare Analyst Tewari holds a conference call with CEO Niklason, CFO Sander and CCO Scheessele on August 23 at 1 pm hosted by Jefferies. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BMRN:
- BioMarin participates in a conference call with Jefferies
- BioMarin treatment of hypochondroplasia granted FDA orphan status
- BioMarin price target lowered to $108 from $118 at Stifel
- BioMarin raises FY23 non-GAAP EPS view to $1.85-$2.10 from $1.80-$2.05
- BioMarin Announces Strong Second Quarter 2023 Results and Record Breaking Revenues for the First Half of 2023, Including 13% Year Over Year Growth Year-to-date